Back
Top 54%
11.6%
Top 28%
7.6%
Top 0.7%
7.6%
Top 0.4%
6.3%
Top 19%
5.8%
Top 0.3%
5.8%
Top 0.7%
4.1%
Top 0.1%
3.8%
Top 2%
3.0%
Top 16%
2.7%
Top 8%
1.9%
Top 2%
1.9%
Top 5%
1.9%
Top 3%
1.9%
Top 12%
1.9%
Top 3%
1.5%
Top 8%
1.5%
Top 18%
1.5%
Top 14%
1.3%
Top 13%
0.9%
Top 9%
0.9%
Top 5%
0.7%
Top 6%
0.7%
Top 3%
0.7%
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver Disease
2026-01-11
gastroenterology
Title + abstract only
View on medRxiv
Show abstract
Introduction and ObjectivesMetabolic dysfunction-associated steatotic liver disease (MASLD) affects about one-quarter of adults worldwide, and liver fibrosis is its strongest predictor of liver-related morbidity and mortality. Using combined in-silico screening and clinical validation, we aimed to identify circulating biomarkers associated with fibrosis progression. Fibulin-3 was identified, and its diagnostic performance was evaluated in biopsy-proven MASLD cohorts. Materials and MethodsThe GS...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
Scientific Reports
701 training papers
3
American Journal of Gastroenterology
15 training papers
4
Gut
17 training papers
5
Nature Communications
483 training papers
6
Gut Microbes
15 training papers
7
iScience
74 training papers
8
Biomedicines
21 training papers
9
JCI Insight
63 training papers
10
eLife
262 training papers
11
Frontiers in Medicine
99 training papers
12
Cell Reports Medicine
49 training papers
13
PLOS Medicine
95 training papers
14
Cell Genomics
34 training papers
15
BMC Medicine
155 training papers
16
eBioMedicine
82 training papers
17
Frontiers in Immunology
140 training papers
18
Clinical Infectious Diseases
219 training papers
19
Journal of Clinical Medicine
77 training papers
20
Nature Medicine
88 training papers
21
Nature Genetics
72 training papers
22
Nutrients
43 training papers
23
BMC Cancer
21 training papers
24
Frontiers in Pharmacology
27 training papers